NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.59
+0.67 (2.69%)
Sep 2, 2026, 4:00 PM EDT - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $3.06 billion as of September 2, 2026. Its market cap has increased by 12.93% in one year.
Market Cap
3.06B
Enterprise Value
2.38B
1-Year Change
12.93%
Ranking
Category
Stock Price
$25.59
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.06B, an increase of 1,880.56%. That is a compound annual growth rate of 70.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.06B | -23.10% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 3.27B |
| Tarsus Pharmaceuticals | 3.26B |
| Immunome | 3.11B |
| Celldex Therapeutics | 3.11B |
| Disc Medicine | 3.02B |
| Arcutis Biotherapeutics | 3.01B |
| MBX Biosciences | 2.97B |
| Beam Therapeutics | 2.94B |